Hunan Hansen Pharmaceutical Co Ltd (002412) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Hunan Hansen Pharmaceutical Co Ltd (002412) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.51 Million ≈ $7.68 Million USD) by net assets (CN¥2.26 Billion ≈ $330.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hunan Hansen Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Hunan Hansen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Hunan Hansen Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Hunan Hansen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Hansen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Great Lakes Dredge & Dock NASDAQ:GLDD	0.098x
Stewards Inc. NASDAQ:SWRD	N/A
Beihai Gofar Marine Biological Industry Co Ltd SHG:600538	-0.013x
Wildcat Resources Ltd AU:WC8	-0.002x
China Chippacking Technology Co. Ltd. A SHG:688216	N/A
Nanjing University Environmental SHE:300864	0.007x
ADLINK Technology Inc TW:6166	0.098x
Changchun Gas Co Ltd SHG:600333	-0.006x

Annual Cash Flow Conversion Efficiency for Hunan Hansen Pharmaceutical Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Hansen Pharmaceutical Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see Hunan Hansen Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.20 Billion ≈ $322.42 Million	CN¥130.78 Million ≈ $19.14 Million	0.059x	-27.60%
2023-12-31	CN¥1.96 Billion ≈ $287.25 Million	CN¥160.95 Million ≈ $23.55 Million	0.082x	+7.99%
2022-12-31	CN¥1.89 Billion ≈ $277.17 Million	CN¥143.81 Million ≈ $21.04 Million	0.076x	-37.76%
2021-12-31	CN¥1.74 Billion ≈ $254.95 Million	CN¥212.54 Million ≈ $31.10 Million	0.122x	+19.95%
2020-12-31	CN¥1.59 Billion ≈ $233.36 Million	CN¥162.19 Million ≈ $23.73 Million	0.102x	-5.76%
2019-12-31	CN¥1.53 Billion ≈ $223.88 Million	CN¥165.11 Million ≈ $24.16 Million	0.108x	-32.36%
2018-12-31	CN¥1.36 Billion ≈ $199.50 Million	CN¥217.52 Million ≈ $31.83 Million	0.160x	+81.50%
2017-12-31	CN¥1.22 Billion ≈ $178.41 Million	CN¥107.18 Million ≈ $15.68 Million	0.088x	-31.35%
2016-12-31	CN¥1.26 Billion ≈ $184.16 Million	CN¥161.16 Million ≈ $23.58 Million	0.128x	+152.48%
2015-12-31	CN¥1.25 Billion ≈ $183.42 Million	CN¥63.57 Million ≈ $9.30 Million	0.051x	-31.23%
2014-12-31	CN¥1.15 Billion ≈ $168.75 Million	CN¥85.05 Million ≈ $12.44 Million	0.074x	+7.35%
2013-12-31	CN¥1.11 Billion ≈ $162.08 Million	CN¥76.09 Million ≈ $11.13 Million	0.069x	-33.85%
2012-12-31	CN¥965.11 Million ≈ $141.23 Million	CN¥100.23 Million ≈ $14.67 Million	0.104x	+70.44%
2011-12-31	CN¥883.65 Million ≈ $129.31 Million	CN¥53.84 Million ≈ $7.88 Million	0.061x	+157.83%
2010-12-31	CN¥898.82 Million ≈ $131.53 Million	CN¥21.24 Million ≈ $3.11 Million	0.024x	-89.66%
2009-12-31	CN¥179.51 Million ≈ $26.27 Million	CN¥41.02 Million ≈ $6.00 Million	0.228x	-12.30%
2008-12-31	CN¥130.26 Million ≈ $19.06 Million	CN¥33.94 Million ≈ $4.97 Million	0.261x	-39.43%
2007-12-31	CN¥87.77 Million ≈ $12.84 Million	CN¥37.75 Million ≈ $5.52 Million	0.430x	--

About Hunan Hansen Pharmaceutical Co Ltd

SHE:002412 China Drug Manufacturers - Specialty & Generic

Market Cap

$514.70 Million

CN¥3.52 Billion CNY

Market Cap Rank

#12392 Global

#3848 in China

Share Price

CN¥6.99

Change (1 day)

-0.29%

52-Week Range

CN¥5.64 - CN¥8.02

All Time High

CN¥51.53